Identification and antibiotic susceptibility of bacterial isolates from probiotic products

被引:349
作者
Temmerman, R
Pot, B
Huys, G
Swings, J
机构
[1] Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium
[2] BCCM, LMG Bacteria Collect, B-9000 Ghent, Belgium
关键词
probiotics; label correctness; identification; antibiotic susceptibility testing;
D O I
10.1016/S0168-1605(02)00162-9
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
In the present study, a total of 55 European probiotic products were evaluated with regard to the identity and the antibiotic resistance of the bacterial isolates recovered from these products. Bacterial isolation from 30 dried food supplements and 25 dairy products, yielded a total of 268 bacterial isolates selected from several selective media. Counts of food supplements showed bacterial recovery in 19 (63%) of the dried food supplements ranging from 103 to 106 CFU/g, whereas all dairy products yielded growth in the range of 10(5)-10(9) CFU/ml. After identification of the isolates using whole-cell protein profiling, mislabeling was noted in 47% of the food supplements and 40% of the dairy products. In six food supplements, Enterococcus faecium was isolated whereas only two of those products claim this species on their label. Using the disc diffusion method, antibiotic resistance among 187 isolates was detected against kanamycin (79% of the isolates), vancomycin (65%), tetracycline (26%), penicillinG (23%), erythromycin (16%) and chloramphenicol (11%). Overall, 68.4% of the isolates showed resistance against multiple antibiotics including intrinsic resistances. Initially, 38% of the isolated enterococci was classified as vancomycin resistant using the disc diffusion method, whereas additional broth dilution and PCR assays clearly showed that all E. faecium isolates were in fact vancomycin susceptible. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 30 条
  • [1] GENETICS AND MECHANISMS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI
    ARTHUR, M
    COURVALIN, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1563 - 1571
  • [2] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
  • [3] Functional foods and health claims legislation: Applications to dairy foods
    Berner, LA
    O'Donnell, JA
    [J]. INTERNATIONAL DAIRY JOURNAL, 1998, 8 (5-6) : 355 - 362
  • [4] Antibiotic susceptibility of potentially probiotic Lactobacillus species
    Charteris, WP
    Kelly, PM
    Morelli, L
    Collins, JK
    [J]. JOURNAL OF FOOD PROTECTION, 1998, 61 (12) : 1636 - 1643
  • [5] HIGH-LEVELS OF SPONTANEOUS DRUG-RESISTANCE IN LACTOBACILLUS
    CURRAGH, HJ
    COLLINS, MA
    [J]. JOURNAL OF APPLIED BACTERIOLOGY, 1992, 73 (01): : 31 - 36
  • [6] de Vrese M, 2001, AM J CLIN NUTR, V73, p421S, DOI 10.1093/ajcn/73.2.421s
  • [7] DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR
    DUTKAMALEN, S
    EVERS, S
    COURVALIN, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) : 24 - 27
  • [8] Enterococci at the crossroads of food safety?
    Franz, CMAP
    Holzapfel, WH
    Stiles, ME
    [J]. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1999, 47 (1-2) : 1 - 24
  • [9] Hamilton-Miller JMT, 1999, PUBLIC HEALTH NUTR, V2, P223, DOI 10.1017/S1368980099000282
  • [10] Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders
    Hoa, NT
    Baccigalupi, L
    Huxham, A
    Smertenko, A
    Van, PH
    Ammendola, S
    Ricca, E
    Cutting, SM
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (12) : 5241 - 5247